Sloan Kettering Executive Turns Over Windfall Stake in Biotech Start-Up

With the cancer center’s corporate ties under scrutiny, the hospital told employees that no one should profit personally from representing MSK on outside boards. The New York Times By KATIE THOMAS and CHARLES ORNSTEIN from NYT Health https://ift.tt/2xOKzCv
Hospitals, Boards of Directors